Login to Your Account



H7N9 vaccine candidates ready for fast-track trials as outbreak in China grows

By Cornelia Zou
Staff Writer

Wednesday, February 5, 2014

HONG KONG – In the wake of an outbreak, two Chinese vaccine makers have filed applications for clinical trials for their vaccines for H7N9 avian flu and are waiting for approvals from the China Food and Drug Administration (CFDA).

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription